Backed by peer-reviewed scientific data, the NasoNeb® Nasal Nebulizer is the fast, convenient solution for complete drug delivery coating to the nasal and paranasal sinus cavities providing low-volume, high concentration delivery. The NasoNeb® Nasal Nebulizer delivers large particles that are readily filtered by the nasal passages to ensure a large percentage of medication is delivered only to the target organ, avoiding the lungs. These particles are delivered via a positive pressure airstream that coats the entire sino-nasal cavity with the medication.1, 2

NasoNeb® Nasal Nebulizer

People who may benefit from topical pharmaceutical therapy delivered by the NasoNeb® Nasal Nebulizer include but are not limited to the following:

  • Post-operative sinus surgery patients with recurrent nasal polyps
  • Post-sinus surgery patients with chronic nasal crusting and infection
  • Patients with bacterial or fungal infections who are not candidates for sinus surgery
  • Patients with other sinus conditions
  • Patients suffering from recurrent allergic rhinitis

Ladd Family Pharmacy prepares customized medications for nasal nebulization using Loxasperse, an innovative powder base. A unique proprietary blend of micronized xylitol and polymers, Loxasperse™ is designed to enhance dispersability and solubility of actives and has been shown to increase activity against biofilms.

By combining multiple drugs into a single dosage form, Loxasperse™can simplify nasal therapy regimens.

To learn more about NasoNeb® and Loxasperse™, contact Ladd Family Pharmacy today.

Manes RP, Tong L, Batra PS. “Prospective evaluation of aerosol delivery by a powered nasal nebulizer in the cadaver model” Int Forum Allergy Rhinol, 2011; 1:366–371

Yuri M. Gelfand, MD; Samer Fakhri, MD; Amber Luong, MD, PhD; Seth J. Isaacs, MD & Martin J. Citardi, MD: “A Comparative Study of the Distribution of Normal Saline Delivered by Large Particle Nebulizer vs. Large Volume/Low Pressure Squeeze Bottle” 56th Annual Meeting of the American Rhinologic Society, September 25, 2010, page 38

PCCA 2013 Loxasperse™. Available at